Gautam Wali Selected Research

Paraplegia (Spastic Paraplegia)

1/2023	Outcome Measures and Biomarkers for Clinical Trials in Hereditary Spastic Paraplegia: A Scoping Review.
9/2018	Expanding the spectrum of PEX16 mutations and novel insights into disease mechanisms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gautam Wali Research Topics

Disease

3	Hereditary Spastic Paraplegia 01/2023 - 05/2014
2	Paraplegia (Spastic Paraplegia) 01/2023 - 09/2018
2	Dystonia (Limb Dystonia) 01/2019 - 09/2018
1	Dysequilibrium syndrome 05/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Neoplasms (Cancer) 01/2020
1	Fucosidosis 01/2019
1	Cerebellar Ataxia (Dysmetria) 09/2018
1	Ataxia Telangiectasia (Louis Bar Syndrome) 06/2013

Drug/Important Bio-Agent (IBA)

3	TubulinIBA 01/2023 - 05/2014
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2021
1	sperm releasing substanceIBA 01/2023
1	VLDL LipoproteinsIBA 05/2021
1	alpha-L-Fucosidase (Fucosidase)IBA 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 09/2018
1	Proteins (Proteins, Gene)FDA Link 06/2013
1	Ataxia Telangiectasia Mutated ProteinsIBA 06/2013

Therapy/Procedure

1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2019
1	Transplantation 01/2019